University of Rhode Island

DigitalCommons@URI
Infectious Diseases in Corrections Report (IDCR)
1-2000

HEPP News, Vol. 3 No. 1
HIV Education Prison Project

Follow this and additional works at: https://digitalcommons.uri.edu/idcr

Recommended Citation
HIV Education Prison Project, "HEPP News, Vol. 3 No. 1" (2000). Infectious Diseases in Corrections Report
(IDCR). Paper 11.
https://digitalcommons.uri.edu/idcr/11

This Article is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion
in Infectious Diseases in Corrections Report (IDCR) by an authorized administrator of DigitalCommons@URI. For
more information, please contact digitalcommons@etal.uri.edu.

HEPP News is sponsored by the Brown University School of Medicine Office of Continuing Medical Education and the Brown University AIDS Program

J a n u a r y

2 0 0 0

About



Vo l u m e

Hepp

HEPP News, a forum for correctional
problem solving, targets correctional
administrators and HIV/AIDS care
providers including physicians, nurses,
outreach workers, and case managers.
Published monthly and distributed by fax,
HEPP News provides up-to-the-moment
information on HIV treatment, efficient
approaches to administering HIV treatment
in the correctional environment, national
and international news related to HIV in
prisons and jails, and changes in correctional care that impact HIV treatment.
Continuing Medical Education credits are
provided by the Brown University Office of
Continuing Medical Education to physicians who accurately respond to the questions on the last page of the newsletter.
The editorial board and contributors to
HEPP News include national and regional
correctional professionals, selected on the
basis of their experience with HIV care in
the correctional setting and their familiarity
with current HIV treatment. We encourage
submissions, feedback, and correspondence from our readership.
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Public Health/Correctional Partnerships
at the Millennium
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At long last, politicians, public health officials
and the lay public are recognizing that the
correctional health unit, as Bureau of Prisons
Medical Director, Dr. Newton Kendig puts it,
lies "at the nexus of public health." (Full
speech from the National Conference on
Correctional Health Care located on page 4.)
Why are our care decisions public health
decisions? Simply put: corrections is the setting where our nation's most at-risk persons
access organized health care.
The topic of creating links between public
health and corrections was the focus of two
recent meetings: the HIV/AIDS Behind Bars
Pre-conference, organized by the HIV
Education / Prison Project at the National
Conference on Correctional Health Care on
November 5, 1999, and the Integrating Public
Health and Corrections Collaborations
Conference in Chicago, October 5-7, 1999.
Both meetings were well attended by correctional health providers, wardens, sheriffs, and
public health officials - more than 100 correctional specialists attended the Ft. Lauderdale
pre-conference, filling the conference room to
capacity. The Chicago meeting featured an
inspirational plenary offering by the Reverend
Jesse Jackson, who reminded the audience
that we are "all under one big tent," thus decisions about health care made inside prison
and jail walls have an impact on the
community at large.
This article will provide you with the ingredients successful public health and correctional
collaborations related to HIV care, and suggestions on the types of programs that might
be implemented in correctional settings, as
described by the speakers at both conferences. In the new millennium, the solution to
providing improved correctional health care
while retaining control of the correctional budget may well be to create links between correctional health care and public health programs.

HIV Testing
Public health HIV testing programs exist in
every state. The tests are offered at local
departments of health, local clinics, health
care vans, and substance abuse centers
through funding by departments of health. In
the past, correctional systems have been
able to take advantage of partnerships with
state and city departments of health to perform HIV testing in correctional settings; in
some cases, public health workers may be
recruited to perform HIV pre-counseling and
screening at intake.
Correctional systems should contact their
state departments of health to inquire whether
the DOH is willing to support the cost of HIV
testing at intake, at least in part, or perform
the HIV test at a discounted rate (compared
to commercial laboratories).
HIV Treatment
In the pre-managed care era, some state
departments of health were responsible for
providing HIV care to jails and prisons. In
some states, this model still exists, while in
others, DOH activities have shifted.
In Rhode Island for example, the existing
HIV care program was initiated as a RI
State Department of Health project. The
department of health shifted its funding support from treatment to prevention, as the
Rhode Island Department of Corrections
assumed fiscal responsibilities for the treatment of the incarcerated. At present, the
Rhode Island DOH supports activities associated with case management of HIV positive
inmates as well as various peer education
and prevention activities within the ACI.
For more information on Rhode Island's case
management and peer education programs, contact Lucille Minuto, Assistant
Continued on page 2
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Administrator or Paul Loberti, Chief
Administrator, Office of HIV & AIDS at the
Rhode Island Department of Health at
401.222.2320.
HIV Transitional Case Management
Transitional case management is an important component of discharge planning. It
involves visits to correctional facilities by
community-based case managers who
assist inmates with planning for care after
release and provide a support network for
the patient after his or her return to the
community.
The States Health Resources and Services
Administration, an agency of the Department
of Health and Human Services, administers
the Ryan White CARE (Comprehensive
AIDS Resources Emergency) Act through
its HIV/AIDS Bureau. The CARE Act was
named in honor of Ryan White, a young
Indiana teenager who died from AIDS in
1990. The CARE Act funds primary health
care and support services for low-income,
uninsured and underinsured individuals and
families affected by HIV/AIDS.
These funds are distributed to states, U.S.
territories and major metropolitan areas;
local planning bodies then determine funding
based upon priorities within the community.
CARE Act funds do not support the provision
of care in correctional facilities (such as that
normally provided by nurses and doctors
working with HIV patients). However, community based organizations who receive
Ryan White funding have provided transitional case management in correctional
facilities (see Table 1).
Funds are available for HIV case management and discharge planning correctional
institutions through the Special Projects of
National Significance (SPNS) Program,
which supports innovative models of
HIV/AIDS care for medically under-served
and hard-to-reach populations. In 1999,
seven states received funds from SPNS and
the Centers for Disease Control to improve
continuity of HIV care once individuals are
released from correctional facilities.
For more information on CARE Act programs, contact your local health department
or Barbara Aranda-Naranjo, PhD, RN,
FAAN, Director of the SPNS Program, at
301.443.9976. (HRSA's website is www.hrsa.gov/hab).
The most successful discharge planning
programs invite community-based HIV care
providers to come into the jail or prison and
arrange for the patient's follow up at the
clinic in the community.
HIV Discharge Medications
Traditionally, correctional systems provide a
supply of medications to inmates upon
release. The amount of medications supplied
is usually linked to the expected delay
between release and re-entry into the community HIV care system, a duration that may
be shortened by providing links to publicly

funded ADAP (AIDS drug assistance programs) at the time of release. See Table 2
for a listing of ADAP contacts in high HIV
prevalence states (contact HIV/AIDS Bureau
at HRSA at 301.443.6745).
One option for correctional HIV providers is
to fill out the ADAP paperwork and obtain
ADAP approval prior to release. The inmate
is then given a contact for the ADAP program
at the time of release and medications can
start as soon as he or she selects a pharmacy. An additional "bridge" for the inmate who
is to be released on medications is now provided by Stadtlanders, one of the major
pharmaceutical contractors to correctional
facilities. Stadtlanders has developed a free
program for discharge medications called
"StadtRelease" (contact Kimberly Betty at
800.833.2510 x31458 or visit the Corrections

Health Care Network archives at www.corrections.com/health/healtharchives.html for
more information).
TB and STD Treatment
Public health programs have consistently
been involved in the diagnosis and treatment
of STDs and TB in correctional settings. The
list of correctional systems with access to
DOH assistance for these diseases is too
long to publish in this space, but would serve
as an indicator of DOH willingness to support
programs addressing the diagnosis and
treatment of diseases that are considered a
"public health concern." It may indeed be
possible to build on existing models of
STD/TB collaborations to increase public
health programmatic support of HIV diagnosis and management in correctional settings.
Continued on page 6

Table 1. Examples of some successful public health/corrections collaborations*
PROGRAM

EXAMPLE

CONTACT

Kerry Grennan
508.875.5258 x147
Health Center
19 Tacoma Street
Worcester, MA 01605

HIV Prevention,
Counseling,
and Testing

Great Brook Valley Health Center and the
Massachusetts DOC (MCI Framingham) Provides HIV
case management, prevention education, counseling and
testing. Funded by the Massachusetts DPH through federal grants and the Ryan White CARE Act.

HIV/STD/TB
Diagnosis

National Center for HIV, STDs, and Tuberculosis
Prevention (NCHSTP). Limited funds are available from
the CDC for screening patients for STDs, TB and HIV in
correctional settings, usually as part of a research project.

NCHSTP
404.639.8011
1600 Clifton Road NE
Mailstop E07
Atlanta, GA 30333

HIV Peer
Education

AIDS Counseling and Education (ACE), at Bedford
Hills Correctional Facility, New York, and Counseling
AIDS Resources Education (CARE) at Taconic Medium
Security Prison, New York, promote HIV harm reduction
among incarcerated women through peer education. The
Womens Prison Association oversees both CARE and
ACE. Funding is provided by the Department of Health
AIDS Institute through the Criminal Justice Initiative and
the Womens Prison Initiative, as well as the Ryan White
CARE Act.
Centerforce, based in San Quentin, CA, is a communitybased organization that does prevention, transition, visitation, and literacy teaching for HIV infected inmates and
their families. Funded by the CDC/HRSA Correctional
Demonstration Grants.

ACE
Liz Mastroenni
914.241.3100 x4360 LM
247 Harris Road
Bedford Hills, NY10507

HIV Correctional
Officer
Education

Correctional Technical Assistance and Training
Project (CTAT), affiliated with Southeast AIDS Training
and Education Center at Emory University, Atlanta, GA,
provides technical assistance to the seven state grantees
of the HRSA/CDC correctional initiative grants. CTAT
also provides training for corrections personnel in GA and
by special contract to other states.

Jackie Zalumas
404.727.2927
735 Gatewood Road NE
Atlanta, GA 30322

HIV Discharge
Planning

Transition Linkage to the Community (TLC) provides
transitional planning for Connecticut inmates that helps
bridge the gap between correction and HIV services in
the community.

Sister Carol Duffy
860.527.1866

HIV Physician
Education

-AIDS Education and Training Centers (AETC) provide
free onsite programs for correctional health care
providers.
-HEPP News is a free monthly fax newsletter that provides up-to-the-moment information on correctional HIV
health care.
-HIV Insite is a website that provides updated information on HIV health care.
-The Hopkins HIV Report is a bimonthly newsletter for
practitioners caring for patients with HIV/AIDS. Their website also provides updated information on HIV care.

Visit: www.hrsa.dhhs.gov

The Illinois AIDS Drug Assistance Program (ADAP)
helps connect qualified jail and prison inmates with the
state ADAP.

Judy Eihansen at
ADAP
800.825.3518

HIV Medication

CARE
Kim Collica
914.241.3010 x6125
Centerforce
415.456.9980 x116
64 Main Street
San Quentin, CA 94964

Call 401.863.2180,
Fax 401.863.1243 or
Visit: www.HIVcorrections.org
Visit: http://hivinsite.ucsf.edu/
The Hopkins HIV Report
P.O. Box 5252
Baltimore, MD 21224
http://hopkins-aids.edu

* Many other examples of such collaborations exist. If you would like to add to this resources list, please call Betsy
Stubblefield at 401.863.2180 or fax to 401.863.1243. This is a work in progress, and will be available on our website:
www.HIVcorrections.org.
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Corrections and public health agencies have not recognized the potential their partnership could have
to benefit the public. They come from very different cultures; they are both busy caring for the most visible needs. Public health differs in two ways from the general health care system: it focuses on a community and emphasizes prevention. Corrections health has focused on individual inmate/patients at
medical call out and emphasized urgent curative care. But corrections is a community, a group of people living in close association, and keeping that community healthy is not only more efficient than waiting to treat after illness occurs or becomes severe but also assures that those being released are
healthier than when they return to the general public. It is far easier to find people and prevent and treat
their health problems while incarcerated than after they return to the "free world."
Where partnerships have developed everyone benefits. In 1996 a fourth of all syphilis cases in Chicago
were found in corrections; disease rates for TB and Hepatitis C may be ten times higher in those entering corrections than in the general population. If the public health goes "where the action is, will corrections health be ready to work with them? In this issue of HEPP News potential partnerships with public health are the common thread. Expect to hear more about these partnerships from many voices this
year. Together we can improve the health of the public as a whole. This can be a truly positive contribution from the stand point of the corrections budget.
Also in this month's HEPP News is an algorithm for stopping prophylaxis for patients on HAART, a spotlight on a new community based discharge planning program in Massachusetts, and public health
resource and contact lists. After reviewing this issue, readers should be able to identify the appropriate
time to cease prophylaxis, distinguish between the various public health resources and grant opportunities for correctional health care, and select the correct antiviral treatments in accordance with the findings of recent studies. Next month's issue will focus on treatment updates.
Thank you for your continued support of HEPP News. We look forward to hearing from you!
Sincerely,

New Options for Initial HIV Treatment
Efavirenz and Two NRTIs
Two studies published in the New England
Journal of Medicine in December (Staszewski et
al., and Starr et al., NEJM. Dec. 16 1999;
341(25): 1865-73, 1874-81) extolled the value of
combining Efavirenz (Sustiva) with two NRTIs.
Dr. Nathan Clumeck compared and commented
on the studies in an editorial entitled "Choosing
the best initial therapy for HIV-1 infection" (192526). The study by Staszewski et al. illustrated the
different perspectives given by an "intent to treat
analysis" (in which every discontinuation of treatment was counted as a treatment failure) and an
"as treated analysis" (which provides a better
assessment of antiretroviral potency). In the
intent to treat analysis, efavirenz (EFZ, Sustiva),
lamivudine (3TC, Epivir) and zidovudine(AZT,
ZDV, Retrovir) appeared to be more effective
than the alternative regimen because more
patients "failed" the alternative (indinavir [IDV,
Crixivan], ZDV, 3TC). When the data published in
Staszeweski et al. was viewed from the "as treated" perspective, according to Dr. Clumeck, the
two regimens appeared to be more or less equivalent. (However, the authors stated that the
Efavirenz containing regimen had superior antiviral potency). Dr. Clumeck reminded his audience
that we're still awaiting longer term comparisons
of protease inhibitor containing regimens and
regimens containing NNRTIs instead of PIs.
(Editor's note: Efavirenz is attractive for correctional use because it is "once a day" and requires
fewer pills (three, for the standard 600 mg QHS
dose) than some protease inhibitors. Abacavir is
associated with rash, myalgia in fever in a significant proportion of patients, and several patients
have died after developing the rash and then
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being re-challenged with Abacavir (Escaut-L;
Liotier-JY; Albengres-E; Cheminot-N; Vittecoq-D.
Abacavir rechallenge has to be avoided in case
of hypersensitivity reaction [letter] AIDS.1999 Jul
30; 13(11): 1419-20.) Discriminating between
Abacavir toxicity and the flu is critical for correctional HIV providers. Correctional HIV providers
using Abacavir may wish to use the Abacavir
rash/fever evaluation protocol developed by Dr.
Rick Altice and published in April HEPP News.
Efavirenz has also been noted to be associated
with CNS effects such as vivid dreams and mood
changes in a significant proportion of patients;
effects that may either positively or negatively
impact on adherence by correctional patients.
Anecdotal reports of recreational Efavirenz use
have arrived at HEPP News from the West
Coast.)
Protease Inhibitors More Effective at
Suppressing HIV-1 in Lymphoid Tissue
When compared to NRTIs alone, protease
inhibitor containing regimens were more effective
in the suppression of HIV-1 replication in lymphoid tissues according to a study published by
L. Ruiz et al. AIDS 1999; 13(1): F1-F8. Lymphoid
tissue was obtained from 12 patients, four of
whom were receiving multiple NRTI therapy and
one who was "sub-optimally" dosed with PIs, and
seven patients who had received PI therapy for at
least 6 months prior to biopsy. Protease inhibitorcontaining regimens appeared to more effectively reverse HIV-induced immunopathological
changes in the lymphoid tissue. Protease
inhibitors have also been associated with loss of
viral fitness. These potential benefits of protease
inhibitor therapy are worth considering when
decisions related to initial or sequential antiretroviral treatment is being considered.

BID Nelfinavir Approved by FDA
Based on information reported in a study conducted by A Peterson, F. Antunes, KN Arasteh,
FD, Gobel, J Gonzalez and others and reported
in Abstract number 205 at the Seventh European
Conference on Clinical Aspects and Treatment of
HIV infection (Lisbon, Portugal, October 23-27,
1999), the FDA recently approved a modification
of Nelfinavir dosing from 750 TID to 1250 BID.
Study AG 1343-542 compared the long-term
antiviral efficacy of bid versus tid dosing of nelfinavir in combination with d4t and 3Tc. The study
showed that 1250 mg bid and 750 TID achieved
equivalent efficacy and safety beyond 48 weeks.
This is an important dose modification that will
simplify protease inhibitor-containing regimens in
correctional settings. By comparison, Indinavir
(crixivan) is dosed three times daily at eight hour
intervals. The combination of Ritonavir (Norvir)
and Saquinavir (Fortovase) is an alternative BID
regimen. (Abstract available at http://www.euroaids99.com.)
Preview of February HEPP News
Main article: HIV Treatment Update. Editors
Joe Bick and Anne De Groot will summarize and
comment on the current treatment guidelines.
HIV 101: Listing of current HAART Therapy
regimens.
HEPPigram: Algorithm for restarting HAART
after re-incarceration
Spotlight: 7th Retrovirus Conference (San
Francisco) : Joe Bick, Anne De Groot, and Rick
Altice will bring you the latest update on correctional HIV management.
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SPECIAL REPORT - The State of Correctional Health Care at the End of the Millennium
From the National Conference on Correctional Health Care, Ft. Lauderdale, Florida, Nov. 1999
Captain Newton E. Kendig, MD,

Medical Director, Federal Bureau of Prisons

HEPP News received permission to reprint Dr. Kendig's speech from the
NCCHC. The text of the original has been edited to conform to HEPP News
space requirements. The opinions expressed in this speech are those of
the author and do not necessarily represent the opinions of the Federal
Bureau of Prisons or the Department of Justice.
The importance of health care in America's jails and prisons has never been
greater. Last month, the National Center for Health Statistics reported continued
declines in deaths from heart disease, cancer, and stroke, and dropped AIDS
as a major cause of mortality.1 Despite these achievements, the Census Bureau
recently announced that the number of persons without health insurance
climbed last year to 44 million Americans.2 The lack of health care coverage
remains concentrated among the uneducated, immigrants, and the otherwise
disadvantaged, who have not proportionally benefited from our advances in
health care. Despite our country's affluence and medical achievements, we
have yet to determine how to deliver health care equitably and cost-effectively
to all Americans.
In recognition of our problems with health care delivery, the Surgeon General
has issued a list of priorities for the nation:3 (1) develop a more balanced health
system by encouraging universal access to health care including mental health
and healthy starts for every child, (2) maintain a global approach to disease prevention and health promotion, and (3) eliminate racial and ethnic disparities in
health.
As correctional health care providers we are poised not only to help meet these
priorities, but to play an essential and pivotal role. Correctional health care has
become a critical nexus for public health interventions, since it is where our
nation's most at-risk persons access organized health care. It has been stated
that corrections is a microcosm of society, but perhaps it should be restated that
society is a macrocosm of corrections, because prisons are not self-contained.
The treatment of inmates directly affects and reflects on society at large. Our
patients increasingly have more of the problems that most significantly affect
our society: violent behavior, substance abuse, mental illness, and infectious
diseases. Our challenge has never been greater.
Larger Numbers of Inmates, Longer Sentences
Prison populations continue to grow in both State and Federal systems. At yearend 1998, more than 1.8 million U.S. residents were in either jail or prison.4 Last
year, the Bureau of Prisons added approximately 10,000 inmates to its population and anticipates continued growth.
Not only do we manage more inmates than ever before, our inmates are our
patients for longer periods of time and present with increasingly complex medical problems. A significant proportion of inmate morbidity is related to substance abuse. Approximately 60-80% of the nation's correctional population
have used drugs at some point in their lives, twice the estimated drug use of the
total U.S. population.5 Between 1980 and 1994, the average sentence imposed
on drug offenders increased from 47 to 80 months.6,7 As persons with substance
abuse histories spend more time incarcerated, the opportunities to provide drug
treatment are shifting from the community to jails and prisons.
Although the press recently described jails and prisons as "incubators of infectious disease,"8 in reality, the prevalence of infectious diseases there largely
results from previously infected inmates entering the correctional systems. Jails
and prisons can fuel infectious disease outbreaks, just as hospitals can, by the
sheer concentration of high risk populations; but these same systems have a
proven role in identifying, treating, and controlling communicable diseases.
HIV, STDs, and TB
State prisons in high prevalence areas are key sites for diagnosing new cases
of HIV in persons at risk, who were previously unaware of their infection. This
dramatic two-year decline has been achieved in a population at high risk of
treatment failure due to ongoing substance abuse prior to incarceration. Jailbased screening for sexually transmitted diseases (STDs) is now recognized by
large city health departments as a proven strategy for curbing syphilis outbreaks
and identifying asymptomatic high risk populations for other STDs.9 The decline

in tuberculosis (TB) incidence in the U.S. is in part the result of TB screening
programs in urban jails and the completion of directly observed therapy in long
term prisons.
Despite our successes in containing communicable diseases. TB epidemics
continue unabated in most parts of the world; and multi-drug resistant TB has
become a global problem.10 Effective TB control programs in jails and prisons
will be essential to our national efforts to further control TB, or approach TB
elimination.
Hepatitis C
Hepatitis C viral (HCV) infection presents perhaps the most daunting challenge
for correctional providers, because of the marked prevalence of this chronic
infection among inmates. Correctional health care providers must take an
increasing role in establishing treatment standards for HCV, since the responsibility for managing infected persons will be centered in U.S. jails and prisons.
Mental Illness
A recent correctional health publication reported that jails and prisons house
more mentally ill individuals than hospitals and chronic care mental institutions.11
The institutions housing the chronically mentally ill in America are our large
urban jails. The Bureau of Justice Statistics reported that nearly 300,000 mentally ill offenders were held in the nation's state and federal prisons by midyear
1998 and nearly twice as many mentally ill persons were on probation in the
community.12 Identifying and treating inmates with mental illness has important
public health and public safety ramifications, since offenders with mental illness
are more likely to commit a violent offense or be nonadherent to recommended
behavior changes and treatments that may curb disease transmission.
The Team Model
Inmates as patients are more complicated than ever before, challenging our traditional models of health care delivery. The Bureau of Prison's Health Services
Division is drafting a new mission statement: "to provide inmates access to
essential quality health care in a cost effective manner." The Bureau of Prisons
is reviewing various methods of primary care delivery for inmates. In one model,
a team approach is used for providing care. Every inmate is assigned to a
health care team. Chronically ill inmates are routinely scheduled for evaluation.
A nurse triage system evaluates inmate complaints and schedules follow-up
appointments. Using this model, only inmates with true emergencies or urgent
health needs are seen on an unscheduled basis. This model is supported by an
inmate co-pay system for certain services and by ready access to certain overthe-counter medications in the commissary.
Determining the level of care provided to inmates is as important as ensuring
access to health care. Whether administrators or direct providers, correctional
workers walk a fine line in deciding what level of care to provide. In reality there
is no accepted community standard for health care in the U.S. because established health plans differ widely in the services they provide.
BOP Core Values
The Federal Bureau of Prisons is attempting to better define essential care for
inmates and has identified several core values that should underpin the
Bureau's scope of services, including: treating all inmates equally, "doing no
harm," respecting inmate autonomy in treatment decisions, recognizing the
importance of treatment on inmate function in activities of daily living, cost
effectiveness, protecting public health, and ensuring public safety. The Bureau's
goal is to provide inmates the highest quality of care, within the defined scope
of services, without compromising core values.
The Bureau's mission is not only to provide inmates access to essential quality
care, but also to deliver health care cost-effectively. Health care expenditures
will grow dramatically in the next decade, as much as $1 trillion by some
estimates. Cost containment through traditional managed care efforts has
largely been realized. The escalation of health care budgets will increasingly be
driven by the cost of new technologies and drug therapies.

Continued on page 5
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Ditton, P. M. (1999). Mental Health and Treatment of Inmates and Probationers.BJS: Special Report, U.S. Department of Justice, July.
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SAVE THE
DATES
The 2000 National Conference on
African-Americans and AIDS
February 24-25, 2000
Renaissance Hotel, Washington DC
Contact the Office of CME at
Johns Hopkins. University
Call: 410.955.2959
Fax: 410.955.0807
E-mail: cmenet@jhmi.edu
Visit: www.med.jhu.edu/cme
HIV Pathogenesis, Antiretrovirals,
and Other Selected Issues in HIV
Disease Management
February 11, Atlanta, GA
February 26, Los Angeles, CA
March 8, Boston, MA
Sponsored by the
International AIDS Society
E-mail: cme@iasusa.org
Visit: www.iasusa.org
The Science and Treatment of HIV:
An Advanced CME Course for
Clinicians
March 25-29, 2000
Snowmass Village, CO
Call: 415.561.6725
Fax: 415.561.6740
Sponsored by the
International AIDS Society
National HIV/AIDS Update
Conference
HIV/AIDS at the Crossroads:
Confronting Critical issues
March 14-17, 2000
San Francisco, CA
Call: 514.874.1998
Fax: 514.874.1580
E-mail nauc@total.net
Visit: www.nauc.org.
National Conference on
Pharmaceutical Care to
Underserved Populations
April 3 -4, 2000
Chapel Hill, NC
Call: 919.966.8138
Email: steve_moore@unc.edu
10th Annual Clinical Care
Options for HIV Symposium
May 4-5, 2000
Scottsdale, AZ
Phone: 888.391.3996
Fax: 508.528.7880
E-mail: registration@mail.
medscape.com
Visit: http://hiv.medscape.com
/symposium2000
Drug Use, HIV and Hepatitis:
Bringing it All Together
May 7-10, 2000
Baltimore, MD
Call 877.565.3693
Fax: 301.565.3710
Visit: www.chhatt.net/
conference.htm
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RESOURCES

FUNDING AND PUBLIC HEALTH COLLABORATIONS INFORMATION WEBSITES
National Center for HIV, STD and TB Prevention,
Divisions of HIV/AIDS Prevention
http//www.CDC.gov/nchstp/

AIDS Education Training Centers
http//www.hrsa.dhhs.gov/hab/C/4web/aetcroster.htm

CDC National Prevention Information Network
http//www.cdcnpin.org

National Alliance of State and Territorial AIDS
Directors
http//www.nastad.org

Ryan White CARE Act Information
http://158.72.83.3/hab/care.html

The HIV/AIDS Treatment Information Service
http://www.hivatis.org

Substance Abuse and Mental Health Services
Administration
http//www.samhsa.gov

The Daily HIV Briefing
http://www.aegis.com

Health Resources and Services Administration
http//www.hrsa.dhhs.gov/hab/

The Corrections Connection
http://www.corrections.com

The State of Correctional Health Care at the End of the Millennium

Continued from page 4

The Health Services Division supports models that utilize professional staff the most efficiently, with the
intended result that staff spend the majority of their work
day using their specific skills and training. Health care
delivery has gotten too expensive for us not to maximize
the use of the staffs specific skills. Doctors and midlevel practitioners need to see patients, nurses need to
do nursing care, triage patients and manage clinics, and
they need the support staff.
Evidence Based Disease Management
Evidence-based disease management will be increasingly necessary as more health resources are dedicated
toward preventive health care and the treatment of
chronic illnesses. Structuring therapies through drug formularies alone is no longer sufficient. Pharmaceuticals
have become too expensive and treatment options too
varied. Specific strategies based on evidence-based
data must drive how we treat patients and deliver this
care. This treatment approach not only better utilizes
existing resources, but is also the practice of good
medicine.
The use of telemedicine and the Internet will lessen the
isolation of correctional medicine while furthering public
safety. The challenge will be to use these technologies
strategically to maximize cost efficiency. Interventions
must improve operations at the frontlines, making it easier, not more difficult for doctors to treat inmates. New
data systems must ensure that collected information
provides outcome measures that improve correctional

medicine at the most fundamental level, patient care.
(For recent BOP survey see box).
Discharge Planning
Gains in health care delivery are pyrrhic victories if correctional systems do not improve linkages with community-based providers. Working with corrections is a
strategic necessity for public health and is tangibly
demonstrated by funding opportunities from the Centers
for Disease Control and Prevention and other government and private organizations. Supporting community
linkages for soon-to-be-released inmates is not sufficient in itself; studies must determine what models are
effective. Broader implementation of effective models
will create safer communities and forge support for funding these programs.
Role of Correctional Health Care Providers
As we near the next millennium, what doctors and nurses in U.S. jails and prisons do day in and day out has
never been more important to both public safety and
public health. As prison systems manage larger inmate
populations, with increasingly complex histories of violence, emotional, and medical problems, maintaining
institutional and public safety is paramount. The role of
correctional health care providers in this effort is no
less than essential, yet is frequently under appreciated.
The provision of consistent, quality health care to
inmates means not just healthier inmates, but creates
safer prisons.

BOP Review of State Correctional Facility Health Care Budgets
as reported by Dr. Newton Kendig at the Nov. 99 NCCHC.

Dr. Kendig reported the following findings at the November 1999 NCCHC conference from an independent
survey of State Correctional SystemsI that was funded by the BOP:
Correctional system health budgets increased 9.1%, on average, between FY 1997 and FY 1998,
This growth rate was comparable to rates of increases of overall correctional budgets.
Health care represented, on average, 10.6% of correctional budgets, ranging from 5% to nearly 17%.
Per capita costs ranged from $2.74 per inmate per day to $11.96 per inmate per day with a mean
per capita of $7.15 per inmate per day.
As compared to the Corrections Yearbook 1998, systems in this survey ranged $3.13 below to
$5.70 greater than published rates.

.
.
.
.
.

Factors that accounted for 60% of the difference between high and low per capita cost states:
Type of health care staff (lower cost used fewer mid level practitioners, but physician/inmate ratios did
not differ between high and low cost states).
Contracted employees vs. Correctional employees (lower cost states used more contracted).
Use of capitated contracts (lower cost states used more capitated contracts, or payment in advance
for specific services or service types).
HIV testing at intake¥ (lower costs states were less likely to HIV test at intake).

.
.
.
.

Key:
FY signifies fiscal year.
?The survey did not assess or compare the quality of health care delivered by different systems. No determination
was made as to whether high cost states provided better, equivalent, or lesser standards of care to their inmates
when compared to low cost states.
¥HIV testing at prison entry was probably a proxy for other cost drivers, since the number of inmates with HIV
infection was not different between high and low cost states.
I
Lamb-Mechanick, D. & Nelson, J. (1999), Prison health care survey: an analysis of factors influencing per
capita costs. National Institute of Corrections Report, December.
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Public Health/Correctional Partnerships at the Millennium

Continued from page 2

HIV Education Programs
Free educational material and on-site programs for care providers, patients, and correctional staff are available through a wide
variety of publicly funded resources:
(1) HIV Education for Providers
AETC: Federally supported AIDS
Education and Training Centers (funded
through the Department of HHS) have
recently shifted their focus to address the
needs of correctional HIV providers
(http://www.hrsd.dhhs.gov).
HHS: Additional free HIV treatment
resources include the HHS guidelines for
the management of HIV, opportunistic
infection, which are published on the web
(http://hivatis.org/trtgdlns.html) and updated
yearly by a national panel of experts.
(see page 7, HIV 101).

Publications: The Johns Hopkins HIV
report, HIV Insite (from the University of
California at San Francisco) and the JAMA
HIV website (http://www.hopkins-aids.edu/,
http://hivinsite.ucsf.edu, http://www.amaassn.org/special/hiv/hivhome.htm) are
additional free resources that can be
accessed by correctional HIV providers.
HEPP News: This monthly newsletter is
available at no cost to correctional HIV
providers (fax-back form on page 7; website http://www.corrections.org). HIV
Inside, another quarterly publication, is
available by request from World Health
Communications (see page 8). Both publications provide Continuing Medical
Education credit (CME) for providers. CEU
for pharmacists and nurses will be available later this year.

Table 2. Ryan White/ADAP contact information

State

Central Ryan White Contact
(for information on local RW Committees)

ADAP Contact

California

California DOH
Office of AIDS CARE Section
916.323.8949

Michael Montgomery
Office of AIDS ADAP
916.327.6784

Connecticut

CT DPH
Bureau of Community Health
860.509.7800

Bette Smith
CT Dept Social Services
860.424.5152

Washington DC

Department of Health
202-939-7822

Paul Brown
Agency for HIV/AIDS
202-727-2500

Florida

Florida DOH
Bureau of HIV/AIDS
850.245.4335

Cyndena Hall
DOH HIV/AIDS Program
850.245.4444 x2547

Georgia

Georgia DOH- Prevention Services
Branch
STD/HIV Section
David Johnson 404.657.3100

Libby Brown
Dept of Human Services
404.657.3129

Illinois

Judy Eihausen at ADAP
800.825.3518

Nancy Abraham
DOH AIDS Activities Section
217.524.5983

Massachusetts

DOH HIV/AIDS Bureau
617.624.5300

Mass HIV Drug Assistance
Program
800.228.2714

New Jersey

NJ DOH AIDS Prevention/Control
609.984.5874

Ron Weinstein
DOH Division of AIDS
609.984.6328

New York

NY State DOH AIDS Institute
518.473.7542

AIDS Drug Assistance Program
800.542.2437

Pennsylvania

PA DOH HIV/AIDS Programs
717.783.0479

AIDS Drug Assistance Program
800.922.9384
State AIDS Fact Line:
800.662.6080

Texas

Texas DOH
HIV/STD Services
512.490.2515

Rhonda Lane
Texas DOH
800.255.1090

(2) HIV Education for Patients
Ryan White: Fortunately, patient education-and specifically education by peers-is
a primary focus for public health funding.
Both federal and local programs are accessible to correctional HIV providers. The
best contact for information would be the
Ryan White Committee (through your local
health department). They will provide a list
of community based organizations that are
willing to come to your facility to facilitate
educational programs for inmates.
Other HIV Education Programs: A number of model programs such as ACE
(Bedford Hills, NY), Span (Massachusetts),
and Centerforce (San Quentin, California)
successfully met inmate HIV educational
needs. Some of these programs have
recently demonstrated the positive effects
of HIV education on subsequent HIV risk
behavior after release.2
(3) HIV Education for Staff
Correctional security staff are the "third
partner" in correctional HIV care, since
they control the flow of inmates to medlines
and clinics. In a number of states, AETCfunded programs that have provided education to correctional security staff have
been well-received (see Table 1.) Several
pharmaceutical companies are also developing free programs in recognition of the
important role that correctional officers play
in patient care.
Summary
Correctional interventions in the area of HIV
care have had a dramatic impact in the last
decade, mainly due to the identification and
treatment of HIV infected individuals who
were unaware of their infection prior to
incarceration.3,4,5 Correctional settings can
be where persons at risk learn about HIV,
about how to avoid HIV infection and
become informed consumers, learning how
to manage their disease. However,
advances in HIV treatment in correctional
settings have been uneven at best. Poor
correctional HIV management can have an
adverse impact on public health. Spotty
medication delivery, inattentive prescribing
of HIV medications, and failure to provide
adequate prophylaxis can result in the delivery of inmates who are sicker and more likely to be infected with drug resistant strains of
HIV back to their communities. For an even
more inspirational view of our role as
providers at the nexus of public health, read
Dr. Newton Kendig's plenary speech, in this
issue of HEPP News on page 4.

References:
1
Pharmaceutical companies have also recognized the importance of public health- corrections linkages and were instrumental in providing support for these two
conferences: HIV/AIDS Behind Bars at the Florida NCCHC was supported by an unrestricted grant from Glaxo-Wellcome. Public/Health Corrections collaborations
was supported by an unrestricted grant from Briston-Myers Squibb. Integrating Public Health and Corrections Collaborations was supported by an unrestricted grant
from Bristol Meyers Squibb, with additional support from the CDC, the City of Chicago Public Health, the Health Resources and Services Administration, the National
Institute of Justice, Substance Abuse and Mental Health Services Administration, and in kind contribution from the National Commission on Correctional Health Care.
2
Grinstead, O., Zack, B., Faigeles, B. Health Education & Benefits, April 1, 1998; 26(2) 225-238.
3
Mostashari F, Riley E, Selwyn A, Altice F. J Acquir Immun Def Syndr and Human Retro. Aug 1, 1998; 18(4) 341-8.
4
Hammett, T. M. Prevention and Treatment of HIV/AIDS: An opportunity not yet seized. HEPP News, December 1999; 2(11).
5
Maruschak, L. (1999), HIV in Prisons 1997, Bureau of Justice Statistics Bulletin, U.S. Department of Justice, Washington DC, November 1998.
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Guidelines for stopping Prophylaxis or Maintenance Therapy
in patients with HIV Infection who have responded to a HAART Regimen.
Health and Human Services (HHS) guidelines on treating opportunistic infections now suggest that patients taking expensive and
usually poorly tolerated prophylactic therapy to prevent first episode of disease (e.g., azithromycin or clarithromycin for the prevention of MAC) may stop when CD4 levels have stayed above the threshold for starting prophylaxis for three to six months and there
has been sustained suppression of viral load. This months HIV 101 summarizes the new guidelines. It is critically important for correctional healthcare providers to counsel patients that the new guidelines are only applicable in the presence of a sustained
response to HAART. Should the patient discontinue HAART therapy or exhibit progression on HAART, the need for treatment and
prevention of opportunistic infections should be reassessed.

Criteria*

Pathogen

Comment**

If, as a result of HAART,
the following changes occur

Pneumocystis (PCP)

CD4>200 for more than 3-6 months
(CIII) and sustained VL reduction for 3-6
months (CIII)

Only for primary Prophylaxis

Mycobacterium Avium Complex
(MAI, MAC)

see comments

Only for primary prophylaxis.
Recommendation now supported by
placebo controlled trial.

Toxoplasma Gondii

no criteria given

Not recommended, but implicit in
Pneumocystis guideline.

Cytomegalocirus
(maintenance therapy)

CD4>100-150 for more than 3-6
months(CIII)

Primary prophylaxis is not generally
recommended. Other factors should
also be considered (CII)

Cryptococcosis

no criteria given

Not recommended, but probably safe
for patients with CD4>100 for 3-6
months.

Histoplasmosis

no criteria given

Not recommended, but probably safe
for patients with CD4>100 for 3-6
months.

Rating system:
C= Optional. Evidence for efficacy insufficient to support recommendation for or against, or efficacy may not outweigh adverse consequences.
II = Evidence from at least one well designed, non-randomized trial or other observational studies.
III = Expert opinion.
*If primary prophylaxis, the patient has never had the condition and this treatment prevents primary occurrence. If maintenance, the patient had
the condition and this treatment prevented secondary recurrence.
**The correctional provider will need to carefully consider whether the patient is expected to retain HAART benefit over the long term before discontinuing treatment. For example, one might be wise not to discontinue prophylaxis in patients who are soon to be released.

Adapted from the MMWR report on August 20, 1999 / 48(RR10);1-59, available at
http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/rr4810a1.htm#tab13 and the Johns Hopkins University website: www.hopkins-aids.edu/publications/report/jan00_5.html Copyright © 1997, 1998, 1999 The Johns Hopkins University on behalf of its Division of Infectious Diseases and AIDS
Service. All rights reserved
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Spotlight: New Initiatives in the Massachusetts DOC & DOH
Tim Gagnon is HIV Program Coordinator of the Massachusetts County Jails Program and, with his colleagues at the MA DOH, a recent recipient of one of
the $1 million dollar "Correctional Demonstration Project" grants from HRSA/CDC. We elected to interview Mr. Gagnon about his new grant for this Public
Health/Correctional Linkages issue of HEPP News.
HEPPNews: What has been your involvement with HIV in corrections?
Tim Gagnon: I helped to design a system to deal with HIV throughout the
correctional system, which continues to this day. With some financial help
from the sheriffs and the DPH we were able to get the outside communities
involved. We subcontract a lot of the services in the HIV programs to the
community in order to get HIV a little bit more on everybody's radar.

more complicated social services needs. Studies have shown that the first 68 months on the street are when people are more likely to do something that
will cause them to be re-incarcerated. There are programs that will do this
kind of work (bridging the gap) such as the Fortune Society in New York, and
Span in Boston.

The effect has been really astounding. When we started going in there in '92
I don't think there were more than 125 HIV infected inmates being treated
annually in the whole county-jail system. Last year we provided services
to all 1,500 men and women who are HIV infected- just in the county jail
systems.

HN: Where are the programs going to take place?
TG: We did some analysis on exit patterns where we collect client-level data
on all our county-jail inmates, who represent the biggest number of prison
inmates. Our research has concluded that 90% of all the HIV infected prisoners who are discharged from correctional facilities in Massachusetts go
back to one of 10 communities in the state.

HN: The funding you just received from HRSA and the CDC was to start new
discharge planning in the county jails?
TG: Let me back up a little. When you're talking about jails and houses of
correction you're talking about a very transient, short prison stay for many
more people. On any given day in Massachusetts, there's about 25,000 people that are incarcerated. Roughly half are in the state system and half are
in the county system. The big difference between the state system and the
county system, because of the length of stays, is that any given year, there
may be close to 60,000 admissions to the county jail system, versus a state
system, which usually averages about 3,000 new persons each year.

We then divided the state up into 6 regions. We want community-based
providers from these particular regions to submit proposals to us to do this
work. We'll have someone from this office that will coordinate this statewide
project the way I coordinate the jail stuff statewide. On the micro-side, there
are HIV coordinators in all of the prison and jails in Massachusetts. When
someone is getting ready to leave, part of the discharge plan is to connect
them with the representative from their region who will talk to the potential
client. That's where the relationship is born. Then when the person gets out,
they'll be able to contact this person. In some cases, the person may pick
them up in the jail when he gets out.

Historically, what has happened in the jail and house of corrections populations is that people aren't there long enough for their HIV to become problematic in a clinical sense. Correctional care providers obviously dealt with
the people that they knew about, but most of the work pre-dating the programs we have now was not sustained nor was it comprehensive. It didn't
have to be, because people were never there long enough.

A lot of times we lose people that way. You've spent three months working
on a discharge plan that's contingent on a guy getting a sober bed at a drug
treatment center on June 5, 1999, and for whatever reason, they decide to
release him on May 26. Now this guy has nowhere to go. This happens very
frequently. So we have to have people who are very mobile and very flexible
on the outside who can be reached by being paged or called on the phone.
Part of our budgeting on this program is to put people on the street with laptops and cell phones so that they're totally mobile.

HN: Given that history, you started your new programs?
TG: (Yes). If inmates have some special needs, the case-workers on the
inside will attempt to get those needs addressed. But we don't have a mandate or the ability to follow someone into the community after they have left.
That's where the new money comes in. We've done such a tremendous job
upstream - while people are incarcerated, educating, testing, treating, and
case-managing. We've created a situation where in Massachusetts in any
given year over the past few years, we're discharging anywhere between
1,000 and 1,500 prisoners--men and women with HIV--back to the community. Once they get back there, even if we are able to develop a fairly comprehensive discharge plan for them, you just don't know what's going to
happen to people.
The grant from HRSA and the CDC will fund three initiatives. One is to start
a statewide network of people who will be community based, whose job is to
help transition former prisoners back into their communities. This program,
called the Transition Intervention Project (TIP), is an expansion of a pilot
mental health transition project that the Mass DPH funded starting a year
and a half ago that has a licensed social worker helping prisoners with
adjustment issues. Our staff will work with jails and prisons three months
before someone gets out-regardless of whether the patients are incarcerated in the county or the state or even in the federal system. We're going to
connect our staff to the inmates before they hit the streets in Massachusetts.
The second initiative is to establish a Chlamydia screening program at the
Nashua State Jail in Boston. The third initiative involves prevention education work in the community correctional centers.
We're really excited about this. Even though a person has made great
strides to deal with their addictive behaviors, get involved in some quality HIV
care and have done well while they are incarcerated, there are a lot of problems once they get out. Often they don't have transportation and there might
be language barriers to accessing services. Our programs should be really
helpful, and benefit inmates statewide.
Some of the easier tasks are getting them an appointment for HIV and helping them maintain access to their medications. But quite often the kinds of
services that recently released inmates with HIV need to access do not traditionally have anything to do with HIV. The other problems they face are the

HN: Is there going to be a way for you to measure the success of the
program?
TG: We're working on an evaluation piece for this right now. We'll obviously
be keeping track of the kinds of services people access. We'll create some
unique identifiers for clients to keep track of the kinds of services they'll utilize while they're in this phase of their careers. We'd like to see that people
are staying engaged; if they have mental health issues that they're able to
access mental health treatment, if they're on meds that they stay adherent,
and stay engaged with their medical providers. That's what we're looking for
in terms of outcomes. Certainly if all these things are in place, we would
expect that people are less likely to get back into a behavioral pattern that
will result in re-incarceration, but that remains to be seen.
HN: What is the future of funding for these programs?
TG: Our feeling is that there is a well-funded universe and network of social
services in this state. Certainly it exists with regard to HIV services. It is our
hope that at the end of the funding period, which is three years long, that we
will have better defined this universe of services in terms of which ones these
people need to access more than others. At the end of the funding cycle a
lot of the case management pieces that are being funded by this will most
likely be absorbed by the community based agencies that are funded to provide a lot of these services in the first place. Our goal is to put ourselves out
of business, in a sense.
HN: When does everything begin?
TG: Its happening right now. We're in the process of putting the RFP together and attempting to hire a statewide coordinator. We are negotiating with the
CDC and HRSA some evaluation criteria that we'll build into this.
I think that from the public health standpoint, this is an opportunity that is not
realized on a national level-not only with HIV but especially with Hepatitis C
and STDs. There's a real case to make. If, as a society, we spend a little bit
of money on preventive health care on this population now, we save a lot of
money 5 to 20 years down the road. I would like to advocate this work for
reasons other than cost effectiveness, but often that is the strongest case we
can make for these interventions.
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Self-Assessment Test for Continuing Medical Education Credit
Brown University School of Medicine designates this educational activity for 1 hour in category 1 credit toward the AMA Physicians
Recognition Award. To be eligible for CME credit, answer the questions below by circling the letter next to the correct answer to each
of the questions. A minimum of 70% of the questions must be answered correctly. This activity is eligible for CME credit through
February 29, 2000. The estimated time for completion of this activity is one hour and there is no fee for participation.

True/False:
1.

The combination of efavirenz, lamivudine, and
zidovudine has been found to be more effective
than indinavir, zidovudine, and lamivudine.

2.

Protease inhibitor containing regimens were more
effective in the suppression of HIV-1 replication in
lymphoid tissue than NRTIs alone.

3.

Efavirenz has been noted to be associated with
CNS effects that may impact on adherence by
correctional patients.

4. The Ryan White CARE Act provides which of the
following?
a) Funds that help support provision of care to
incarcerated HIV infected patients.
b) Funds for primary health care and support
services for low-income, uninsured and underinsured
individuals and families affected by HIV/AIDS.
c) Support for research or models of HIV/AIDS
care for medically under-served and hard-to-reach
populations.
d) Assistance with access to HIV medications for
under-served populations.
5. When can cytomegalovirus maintenance therapy prophylaxis
be stopped?
a) When a patient has maintained a CD4 count of 100
for more than 3-6 months, during which time he had
no OI's.
b) When a patient has maintained a CD4 count of 150
for 7 months, during which time he had no OI's.
c) When a patient has maintained a CD4 count of at
least 200 for at least 6 months.

BROWN UNIVERSITY SCHOOL OF MEDICINE  OFFICE

OF

6. Experts suggest is it possible to stop PCP primary prophylaxis
given which criteria?
a) CD4>300 for more than 3-6 months
b) CD4>150 for >6-8 months, and sustained VL
reduction for 3-6 months
c) CD4>200 for >3-6 months and sustained VL
reduction for 3-6 months
d) Not recommended, but probably safe with CD4>100
for 3-6 months
e) Not recommended
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1 Very Poor
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2. Do you feel that HEPP News helps you in your work?
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